fashion -WSS

fashion

author：comprehensive 2025-10-01 15:40:30 - browse：62725

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： FDA official pushes for dedicated emerging pathogens team

hotspot

WSS

This gene therapy has record $4.25 million price. It's saved children.

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Mirador, a new biotech startup, launches with $400 million

Russian special forces kill a gunman who broke into a private house near Moscow

Body of missing toddler recovered in Delaware River days after flood: Police

A double vaccine crisis is endangering millions of children

hotspot

fashion

hotspot

Medical records are filled with copy

Adam's Take: Intra

Walensky prepares to leave CDC — and Congress — behind

Organ transplantation is at a crossroads. Major reform is needed

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Yancopoulos of Regeneron works to expand Dupixent success

FDA approval of Sarepta Duchenne genetic therapy gives me hope

AbbVie dramatically boosts its spending on lobbying

The high cost of giving birth even with insurance

As Taiwan prepares for anti

focus

This gene therapy has record $4.25 million price. It's saved children.

Court strikes down limits on filming of police in Arizona

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Texas board proposes rules on abortion law emergency exemption

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Medical devices makers are asking for forgiveness, not permission

Wikipedia

entertainment

leisure time

entertainment